{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:58:18Z","timestamp":1790398698752,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100024838","name":"Samsung Medical Center, Sungkyunkwan University","doi-asserted-by":"publisher","award":["SMX126002"],"award-info":[{"award-number":["SMX126002"]}],"id":[{"id":"10.13039\/501100024838","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2022-KH129440"],"award-info":[{"award-number":["RS-2022-KH129440"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59093-7","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:25:53Z","timestamp":1782555953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genetic characteristics of RPE65-associated inherited retinal degeneration in Koreans"],"prefix":"10.1038","volume":"16","author":[{"given":"Sungsoon","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Ki","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheon Kuk","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"59093_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/3813","volume":"20","author":"TM Redmond","year":"1998","unstructured":"Redmond, T. M. et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. 20, 344\u2013351. https:\/\/doi.org\/10.1038\/3813 (1998).","journal-title":"Nat. Genet."},{"key":"59093_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajo.2018.09.024","volume":"199","author":"DC Chung","year":"2019","unstructured":"Chung, D. C. et al. The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene. Am. J. Ophthalmol. 199, 58\u201370. https:\/\/doi.org\/10.1016\/j.ajo.2018.09.024 (2019).","journal-title":"Am. J. Ophthalmol."},{"key":"59093_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1167\/iovs.61.4.47","volume":"61","author":"N Kumaran","year":"2020","unstructured":"Kumaran, N. et al. Retinal Structure in RPE65-Associated Retinal Dystrophy. Invest. Ophthalmol. Vis. Sci. 61, 47. https:\/\/doi.org\/10.1167\/iovs.61.4.47 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"59093_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell, S. et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390, 849\u2013860. https:\/\/doi.org\/10.1016\/s0140-6736(17)31868-8 (2017).","journal-title":"Lancet"},{"key":"59093_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","volume":"126","author":"AM Maguire","year":"2019","unstructured":"Maguire, A. M. et al. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. Ophthalmology 126, 1273\u20131285. https:\/\/doi.org\/10.1016\/j.ophtha.2019.06.017 (2019).","journal-title":"Ophthalmology"},{"key":"59093_CR6","doi-asserted-by":"publisher","unstructured":"Fischer, M. D. et al. Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study. Biomolecules 14, 122. (2024). https:\/\/doi.org\/10.3390\/biom14010122","DOI":"10.3390\/biom14010122"},{"key":"59093_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ejhg.2015.241","volume":"24","author":"GD Astuti","year":"2016","unstructured":"Astuti, G. D. et al. Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark. Eur. J. Hum. Genet. 24, 1071\u20131079. https:\/\/doi.org\/10.1038\/ejhg.2015.241 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"59093_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13023-022-02566-5","volume":"17","author":"EH Cho","year":"2022","unstructured":"Cho, E. H., Park, J. E., Lee, T., Ha, K. & Ki, C. S. Carrier frequency and incidence estimation of RPE65-associated inherited retinal diseases in East Asian population by population database-based analysis. Orphanet J. Rare Dis. 17, 409. https:\/\/doi.org\/10.1186\/s13023-022-02566-5 (2022).","journal-title":"Orphanet J. Rare Dis."},{"key":"59093_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13023-021-01807-3","volume":"16","author":"FJ Gao","year":"2021","unstructured":"Gao, F. J. et al. Frequency and phenotypic characteristics of RPE65 mutations in the Chinese population. Orphanet J. Rare Dis. 16, 174. https:\/\/doi.org\/10.1186\/s13023-021-01807-3 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"59093_CR10","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/humu.24492","volume":"43","author":"A Suga","year":"2022","unstructured":"Suga, A. et al. Genetic characterization of 1210 Japanese pedigrees with inherited retinal diseases by whole-exome sequencing. Hum. Mutat. 43, 2251\u20132264. https:\/\/doi.org\/10.1002\/humu.24492 (2022).","journal-title":"Hum. Mutat."},{"key":"59093_CR11","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1111\/aos.14181","volume":"98","author":"S Li","year":"2020","unstructured":"Li, S. et al. RPE65 mutation frequency and phenotypic variation according to exome sequencing in a tertiary centre for genetic eye diseases in China. Acta Ophthalmol. 98, e181\u2013e190. https:\/\/doi.org\/10.1111\/aos.14181 (2020).","journal-title":"Acta Ophthalmol."},{"key":"59093_CR12","doi-asserted-by":"publisher","unstructured":"Shi, J. et al. Clinical Features and Natural History in a Cohort of Chinese Patients with RPE65-Associated Inherited Retinal Dystrophy. J. Clin. Med. 10, 5229 https:\/\/doi.org\/10.3390\/jcm10225229 (2021).","DOI":"10.3390\/jcm10225229"},{"key":"59093_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13816810.2014.991931","volume":"37","author":"S Katagiri","year":"2016","unstructured":"Katagiri, S. et al. RPE65 Mutations in Two Japanese Families with Leber Congenital Amaurosis. Ophthalmic Genet. 37, 161\u2013169. https:\/\/doi.org\/10.3109\/13816810.2014.991931 (2016).","journal-title":"Ophthalmic Genet."},{"key":"59093_CR14","unstructured":"ClinGen Leber Congenital Amaurosis\/Early-Onset Retinal Dystrophy Variant Curation Expert Panel. Specifications to the ACMG\/AMP Variant Interpretation Guidelines for RPE65, Version 1.0.0. Clinical Genome Resource https:\/\/ (2023). erepo.clinicalgenome.org\/cspec\/ui\/svi\/doc\/1566365955"},{"key":"59093_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ceo.13022","volume":"46","author":"DC Chung","year":"2018","unstructured":"Chung, D. C. et al. Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clin. Exp. Ophthalmol. 46, 247\u2013259. https:\/\/doi.org\/10.1111\/ceo.13022 (2018).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"59093_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/jmg.40.9.709","volume":"40","author":"S Yzer","year":"2003","unstructured":"Yzer, S. et al. A Tyr368His RPE65 founder mutation is associated with variable expression and progression of early onset retinal dystrophy in 10 families of a genetically isolated population. J. Med. Genet. 40, 709\u2013713. https:\/\/doi.org\/10.1136\/jmg.40.9.709 (2003).","journal-title":"J. Med. Genet."},{"key":"59093_CR17","doi-asserted-by":"publisher","unstructured":"Stepanova, A. et al. A Molecular Genetic Analysis of RPE65-Associated Forms of Inherited Retinal Degenerations in the Russian Federation. Genes (Basel). 14, 2056. https:\/\/doi.org\/10.3390\/genes14112056 (2023).","DOI":"10.3390\/genes14112056"},{"key":"59093_CR18","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1097\/iae.0000000000002681","volume":"40","author":"LHM Pierrache","year":"2020","unstructured":"Pierrache, L. H. M. et al. LONGITUDINAL STUDY OF RPE65-ASSOCIATED INHERITED RETINAL DEGENERATIONS. Retina 40, 1812\u20131828. https:\/\/doi.org\/10.1097\/iae.0000000000002681 (2020).","journal-title":"Retina"},{"key":"59093_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/iovs.63.2.13","volume":"63","author":"F Testa","year":"2022","unstructured":"Testa, F. et al. RPE65-Associated Retinopathies in the Italian Population: A Longitudinal Natural History Study. Invest. Ophthalmol. Vis. Sci. 63, 13. https:\/\/doi.org\/10.1167\/iovs.63.2.13 (2022).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"59093_CR20","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.ophtha.2004.01.033","volume":"111","author":"B Lorenz","year":"2004","unstructured":"Lorenz, B. et al. Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology 111, 1585\u20131594. https:\/\/doi.org\/10.1016\/j.ophtha.2004.01.033 (2004).","journal-title":"Ophthalmology"},{"key":"59093_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13023-021-01868-4","volume":"16","author":"A Sodi","year":"2021","unstructured":"Sodi, A. et al. RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy. Orphanet J. Rare Dis. 16, 257. https:\/\/doi.org\/10.1186\/s13023-021-01868-4 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"59093_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ymthe.2020.11.029","volume":"29","author":"AM Maguire","year":"2021","unstructured":"Maguire, A. M., Bennett, J., Aleman, E. M., Leroy, B. P. & Aleman, T. S. Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy. Mol. Ther. 29, 442\u2013463. https:\/\/doi.org\/10.1016\/j.ymthe.2020.11.029 (2021).","journal-title":"Mol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59093-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59093-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59093-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:01:59Z","timestamp":1790395319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59093-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59093"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59093-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29562"}}